Franklin Resources Inc. trimmed its position in shares of Danaher Co. (NYSE:DHR) by 0.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,716,225 shares of the conglomerate’s stock after selling 7,207 shares during the quarter. Franklin Resources Inc. owned approximately 0.39% of Danaher worth $252,120,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Zions Bancorporation boosted its position in Danaher by 118.3% during the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares in the last quarter. Patten Group Inc. lifted its position in shares of Danaher by 262.3% in the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after acquiring an additional 3,497 shares in the last quarter. First Personal Financial Services lifted its position in shares of Danaher by 128.9% in the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after acquiring an additional 691 shares in the last quarter. Calton & Associates Inc. purchased a new stake in shares of Danaher in the fourth quarter valued at $114,000. Finally, Truewealth LLC purchased a new stake in shares of Danaher in the fourth quarter valued at $121,000. Institutional investors own 77.83% of the company’s stock.
Several analysts have recently issued reports on the company. Deutsche Bank reduced their price objective on Danaher from $114.00 to $107.00 and set a “buy” rating on the stock in a research report on Thursday, March 1st. Credit Suisse Group restated a “neutral” rating on shares of Danaher in a research report on Friday. Royal Bank of Canada restated a “hold” rating and issued a $98.00 price objective on shares of Danaher in a research report on Wednesday, January 31st. Stifel Nicolaus restated a “buy” rating and issued a $110.00 price objective on shares of Danaher in a research report on Friday, January 19th. Finally, Morgan Stanley upped their price objective on Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a research report on Wednesday, January 31st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $101.23.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The firm had revenue of $5.09 billion for the quarter, compared to the consensus estimate of $4.97 billion. During the same period in the prior year, the business posted $1.05 earnings per share. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. analysts predict that Danaher Co. will post 4.37 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be given a dividend of $0.16 per share. The ex-dividend date is Wednesday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio is 15.86%.
In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the company’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the sale, the senior vice president now directly owns 82,008 shares in the company, valued at $8,388,598.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Rainer Blair sold 51,080 shares of the company’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $97.26, for a total value of $4,968,040.80. Following the sale, the insider now owns 50,477 shares of the company’s stock, valued at $4,909,393.02. The disclosure for this sale can be found here. Insiders have sold 313,260 shares of company stock valued at $31,657,786 over the last 90 days. 12.20% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This report was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/12/danaher-co-dhr-shares-sold-by-franklin-resources-inc.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.